Cyclo Therapeutics Inc. (CYTH)
NASDAQ: CYTH
· Real-Time Price · USD
0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM
Cyclo Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.8M | -20.74M | -19.39M | -20.06M | -19.4M | -18.87M | -17.69M | -15.45M | -13.26M | -12.88M | -13.02M | -14.29M | -14.17M | -11.75M | -10.34M |
Depreciation & Amortization | 11.35K | 13.99K | 16.63K | 19.28K | 19.33K | 19.64K | 19.56K | 19.48K | 18.82K | 17.9K | 18.02K | 16.83K | 16.03K | 14.94K | 13.2K |
Stock-Based Compensation | 779.04K | 998.89K | 818.47K | 736.91K | 694.67K | 611.92K | 570.51K | 626.58K | 204.19K | 390.73K | 518.02K | 420.58K | 879.37K | 578.86K | 314.39K |
Other Working Capital | 1.59M | 415.77K | 213.99K | 431.34K | 2.35M | 2.51M | 2.56M | 1.34M | -1.32M | -1.48M | -1.53M | -1.1M | -2.16M | -2.75M | -2.75M |
Other Non-Cash Items | 2.2M | 2.39M | 324.57K | -2.3M | -2.49M | -2.36M | -865.12K | -148.25K | -45.34K | 103.91K | 1.33M | 1.27M | 1.37M | 1.68M | 437.79K |
Deferred Income Tax | -61.76K | 64.49K | 1.52M | 2.35M | 2.41M | 2.29M | 834.39K | n/a | n/a | n/a | n/a | n/a | -117.35K | -117.35K | -117.35K |
Change in Working Capital | 1.03M | 583.12K | 404.39K | 3.06M | 4.13M | 4.56M | 2.54M | -48.15K | -1.78M | -2.27M | -2.34M | -1.23M | -2.23M | -2.88M | -1.64M |
Operating Cash Flow | -22.52M | -18.37M | -18M | -16.19M | -14.64M | -13.78M | -14.65M | -15.11M | -14.98M | -14.82M | -14.91M | -15.01M | -15.45M | -14.04M | -11.66M |
Capital Expenditures | -2.42K | 3.85M | -2.42K | -2.42K | 15.09K | 4.6K | 4.6K | n/a | 7.41K | 17.9K | -4.6K | n/a | 30.63K | 30.63K | 50.63K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -2.42K | -2.42K | -2.42K | -2.42K | 4.81K | 33.57K | 44.15K | 58.06K | 41.09K | 19.15K | 25.41K | 14.82K | -12.93K | -13.21K | -20.33K |
Investing Cash Flow | -2.42K | -2.42K | -2.42K | -2.42K | 19.89K | 38.17K | 48.75K | 58.06K | 48.5K | 37.05K | 20.81K | 14.82K | 17.7K | 17.42K | 30.3K |
Debt Repayment | 8M | n/a | n/a | n/a | n/a | n/a | n/a | 6.78K | 6.78K | n/a | n/a | -6.78K | -6.78K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.14M | 13.14M | 11.67M | 14.15M | 2.77M | 2.77M | 2.26M | -144.58K | n/a | n/a | 402.01K | 7.99M | 7.99M | 7.99M | 9.71M |
Financial Cash Flow | 21.65M | 18.65M | 20.08M | 23.89M | 12.16M | 7.15M | 3.75M | 13.56K | 10.78M | 10.78M | 11.18M | 18.76M | 21.64M | 24.47M | 26.2M |
Net Cash Flow | -873.8K | 280.28K | 2.08M | 7.7M | -2.49M | -6.61M | -10.88M | -15.07M | -4.15M | -4.01M | -3.71M | 3.77M | 6.2M | 10.45M | 14.57M |
Free Cash Flow | -26.37M | -18.37M | -18M | -16.19M | -14.62M | -13.77M | -14.65M | -15.11M | -14.97M | -14.81M | -14.91M | -15.01M | -15.42M | -14.01M | -11.61M |